Insulin in Dosage Market Size Value Per Capita in Italy

The insulin dosage market size value per capita in Italy has shown notable fluctuations from 2012 to 2022. Starting at 25.26 in 2012, the market saw a decline to 22.09 in 2013 and then to 21.21 by 2015. Although there was a slight recovery to 23.74 in 2016, this was followed by a declining trend, dropping to 19.77 in 2019, before rebounding slightly to 22.45 in 2021, and finally settling at 20.06 in 2022. The two-year YOY variation for 2022 observed a decline, halting the previous slight recovery. Over the past 5 years, the market demonstrated an average annual decrease, with the latest CAGR indicating a downward trend.

Future trends to watch for include the development of new insulin delivery technologies, potential regulatory changes, the impact of health policies on diabetes management, and the implications of new biosimilars entering the market. Additionally, monitoring the influence of lifestyle changes and improved preventive measures on insulin demand will be critical.